This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity
Journal of Immunology Research
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmunotherapy and Immune Responses · Toxin Mechanisms and Immunotoxins · Transgenic Plants and Applications
RETRACTION: L. Zhang, J. Du, Q. Song, C. Zhang, and X. Wu, “A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity,” Journal of Immunology Research 2022 (2022): 1178874, https://doi.org/10.1155/2022/1178874.
The above article, published online on 1 February 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor‐in‐Chief, Nadja Bakocevic; and John Wiley & Sons Ltd.
The retraction has been agreed following an investigation of the concerns raised by Indigofera tanganyikensis on PubPeer [1], which identified an instance of figure duplication.
Specifically, the images of B‐16 and LLC cells treated with 100 μM of RB with isotype control in Figure 2a share unexpected similarities.
As a result of the investigation, the data and conclusions of this article are considered unreliable.
The authors have been informed of this retraction but did not provide a response.
The reference list from the paper itself. Each links out to its DOI / PubMed record.